What's at stake: Family-owned Douglas Pharmaceuticals has appointed a new CEO to accelerate growth, with Jeff Douglas remaining in the managing director role.
The background: The nearly 60-year-old company was founded by the late Sir Graeme Douglas. His eldest son then took over as CEO in 2014 when the founder turned 85. It then had a turnover of $150 million, which has now grown to well over $200m. The new CEO aims to ramp that up further.
The players: Sean Westbrook, Jeff Douglas, Sir Graeme Douglas, Douglas Pharmaceuticals.
Sean Westbrook is not one for resting on his laurels. The new CEO at privately owned Douglas Pharmaceuticals has this year signed up for a Doctor of Business Administration programme at the University of Otago to further hone his commercialisation skills.
Sign up to get the latest stories and insights delivered to your inbox – free, every day.
Key points
What's at stake: Family-owned Douglas Pharmaceuticals has appointed a new CEO to accelerate growth, with Jeff Douglas remaining in the managing director role.
The background: The nearly 60-year-old company was founded by the late Sir Graeme Douglas. His eldest son then took over as CEO in 2014 when the founder turned 85. It then had a turnover of $150 million, which has now grown to well over $200m. The new CEO aims to ramp that up further.
The players: Sean Westbrook, Jeff Douglas, Sir Graeme Douglas, Douglas Pharmaceuticals.
